Compare · LFWD vs STE
LFWD vs STE
Side-by-side comparison of Lifeward Ltd. (LFWD) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LFWD and STE operate in Industrial Specialties (Health Care), so they compete in similar markets.
- STE is the larger of the two at $21.87B, about 1274.5x LFWD ($17.2M).
- Both names hit the wire about 4 times in the past 4 weeks.
- STE has more recent analyst coverage (17 ratings vs 1 for LFWD).
- Company
- Lifeward Ltd.
- STERIS plc (Ireland)
- Price
- -
- -
- Market cap
- $17.2M
- $21.87B
- 1M return
- +0.00%
- -
- 1Y return
- -15.51%
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- 2014
- News (4w)
- 4
- 4
- Recent ratings
- 1
- 17
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest LFWD
- Lifeward’s ReWalk® Personal Exoskeleton Demonstrates Sustained Long-Term Home Use and Patient Satisfaction in Latest Independent Peer-Reviewed Study
- SEC Form 8-K filed by Lifeward Ltd.
- Lifeward Ltd. filed SEC Form 8-K: Leadership Update
- SEC Form DEF 14A filed by Lifeward Ltd.
- SEC Form PRE 14A filed by Lifeward Ltd.
- Lifeward Ltd. filed SEC Form 8-K: Shareholder Director Nominations
- Peer-Reviewed Study of Lifeward’s ReWalk® Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and Pain
- Director Zamir Haggai was granted 6,711 units of Ordinary Shares (SEC Form 4)
- SEC Form 3 filed by new insider Zamir Haggai
- Lifeward Ltd. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
Latest STE
- SEC Form 8-K filed by STERIS plc (Ireland)
- Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)
- STERIS Expands Healthcare Consumables Offering with Definitive Agreement to Acquire Xodus Medical, a Specialty Surgical Products Business Focused on Patient and OR Staff Safety
- SEC Form 4 filed by STERIS plc (Ireland)
- STERIS to Present at the Morgan Stanley Healthcare Conference
- SEC Form 144 filed by STERIS plc (Ireland)
- SEC Form 4 filed by Director Shapiro Louis
- Director Sohi Mohsen exercised 4,058 units of Ordinary Shares at a strike of $86.23 and sold $956,795 worth of Ordinary Shares (4,058 units at $235.78) (SEC Form 4)
- SEC Form 4 filed by Director Shah Nirav R
- SEC Form 4 filed by Director Martin Paul Edward